Dublin, April 26, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Global Immunoglobulin Products Market 2016-2020" report to their offering.

The global immunoglobulin products market is set to grow at a CAGR of 6.84% during the period 2016-2020.

Immunoglobulins, also known as antibodies, are proteins that help neutralize foreign objects such as bacteria and viruses. They help recognize and bind to particular antigens. Based on the difference in the amino acid sequence in the fragment crystallizable (Fc) region of the antibody heavy chain, they can be categorized into the following isotypes:

• IgA
• IgD
• IgE
• IgG
• IgM.
  

Immunoglobulin products are used to treat primary antibody deficiency, complex immune deficiency disorders, and life threatening infections. Immunoglobulin therapeutic products help prevent infections, improving the quality of life and increasing life expectancy.

As plasma therapeutics are often expensive, vendors provide co-pay assistance to patients to enable the purchase of these drugs. For instance, Baxter's Gammagard liquid support program provides financial assistance to individuals with primary immunodeficiency. According to the Gammagard Liquid SubQ CoPay card, an eligible patient receiving treatment with Gammagard Liquid SubQ for primary immunodeficiency is entitled to save up to $2,500 on the coinsurance/co-payment costs over a 12-month period.

According to the report, growing older population is driving the market growth. The immune system becomes weak with age, causing many immune deficiency syndromes. Individuals with immune deficiency require immunoglobulin products for proper functioning of the immune system.

Further, the report states that immunoglobulin products are produced from plasma, and obtaining high-quality plasma is an expensive and challenging exercise. Moreover, the cost of immunoglobulin is dependent on the availability of human donors. Fractionation of plasma is the standard method of producing immunoglobulins and is a highly complex procedure.

Key vendors:

• Baxalta
• Biotest Pharmaceuticals Corp.
• CSL Ltd.
• Grifols SA
• Kedrion SpA
• Octapharma

Key questions answered in this report:

• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Key Topics Covered:

PART 01: Executive summary
PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Plasma products: An overview

PART 06: Regulation of plasma products

PART 07: Pipeline portfolio

PART 08: Market landscape

PART 09: Market segmentation by type of immunoglobulins

PART 10: Market segmentation by application

PART 11: Market segmentation by ROA

PART 12: Market segmentation by volume

PART 13: Geographical segmentation

PART 14: Market drivers

PART 15: Impact of drivers

PART 16: Market challenges

PART 17: Impact of drivers and challenges

PART 18: Market trends

PART 19: Vendor landscape

For more information visit http://www.researchandmarkets.com/research/c45285/global

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         press@researchandmarkets.com

         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716

         

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.